R&G PharmaStudies Co., Ltd. (SHE:301333)
China · Delayed Price · Currency is CNY 62.13
+2.05 (3.41%)
Mar 27, 2026, 4:00 PM EDT
20.78% (1Y)
| Market Cap | 5.91B +17.3% |
| Revenue (ttm) | 851.01M +14.4% |
| Net Income | 136.90M -2.4% |
| EPS | 1.43 -2.7% |
| Shares Out | 95.14M |
| PE Ratio | 43.45 |
| Forward PE | 35.91 |
| Dividend | 0.16 (0.26%) |
| Ex-Dividend Date | Jul 8, 2025 |
| Volume | 2,231,150 |
| Average Volume | 1,637,011 |
| Open | 59.26 |
| Previous Close | 60.08 |
| Day's Range | 58.98 - 62.78 |
| 52-Week Range | 40.99 - 91.78 |
| Beta | 0.71 |
| RSI | 45.05 |
| Earnings Date | Mar 28, 2026 |